← Back to search

Indee Labs

Enabling T cell immunotherapy discovery, development and manufacturing

Y CombinatorWinter 2017ActiveHealthcareDrug Discovery and DeliveryGene TherapyMicrofluidicsCell Therapy

What they do

Problem

Intracellular delivery into T cells is a major bottleneck in T cell immunotherapy discovery, development, and manufacturing.

Solution

Indee Labs provides a non-viral intracellular delivery system using microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins, and gene-editing complexes into T cells with minimal perturbation.

Who it's for

Cell therapy biotechs, pharma companies, and research/manufacturing teams working with patient or donor T cells.

Founders

Ryan Pawell
Founder/CEO

My career aim is to use technology to improve health outcomes. See more on my LinkedIn profile.

Company timeline

Similar startups